Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Transforming growth factor-β (TGF-β) plays a complex role in cancer, influencing various cellular processes.
• Extracellular vesicles (EVs), including exosomes, are increasingly recognized for their role in intercellular communication.
• TGF-β signaling and its regulators within EVs are emerging targets for cancer therapy.

Purpose of the Study:

• To explore the role of TGF-β and its signaling pathway regulators within EVs in cancer progression.
• To investigate how exosomal TGF-β contributes to cancer cell phenotypic plasticity and treatment resistance.
• To understand the mechanisms by which EVs facilitate TGF-β-mediated communication in the tumor microenvironment.

Main Methods:

• Analysis of TGF-β and its pathway regulators in extracellular vesicles.
• Investigating the impact of exosomal TGF-β on cancer cell plasticity and drug resistance.
• Studying EV-mediated intercellular communication and their influence on the metastatic cascade and tumor microenvironment.

Main Results:

• Exosomal TGF-β is implicated in cancer cell phenotypic plasticity, a mechanism that hinders treatment efficacy.
• EVs contribute to the metastatic cascade by modulating the immune system and interacting with extracellular matrix (ECM) proteins.
• These EV-mediated processes create a supportive microenvironment for metastatic tumor growth.

Conclusions:

• Understanding EV-mediated TGF-β communication is crucial for developing novel cancer therapies.
• Targeting EVs and their cargo, such as TGF-β, presents a promising strategy for controlling oncological disorders.
• EVs hold potential as diagnostic and therapeutic targets for improving cancer treatment outcomes.